Cas:502496-36-8 3-Bromo-5-fluoro-2-methylaniline manufacturer & supplier

We serve Chemical Name:3-Bromo-5-fluoro-2-methylaniline CAS:502496-36-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Bromo-5-fluoro-2-methylaniline

Chemical Name:3-Bromo-5-fluoro-2-methylaniline
CAS.NO:502496-36-8
Synonyms:3-Bromo-5-fluoro-2-methylaniline;2-Amino-6-bromo-4-fluorotoluene;3-bromo-5-fluoro-2-methylbenzenamine;Benzenamine, 3-bromo-5-fluoro-2-methyl-;PC2787;5-fluoro-o-toluidinylbromide;3-bromo-5-fluoro-2-methyl-phenylamine
Molecular Formula:C7H7BrFN
Molecular Weight:204.040
HS Code:2921430090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:258.9±35.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.585
PSA:26.02000
Exact Mass:202.974579
LogP:3.00

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Bromo-5-fluoro-2-methylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-5-fluoro-2-methyl-phenylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-5-fluoro-2-methylbenzenamine Use and application,PC2787 technical grade,usp/ep/jp grade.


Related News: Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 2,2-dichloro-5,5,7,7-tetramethyl-4,6-dioxaspiro[2.4]heptane manufacturers Today the international business represents 25 percent of BetterUp’s members, who access the platform through global enterprise partners including Allianz, Hilton, Snap Inc. and Mars. 6-chloro-1,1-dioxo-3-propyl-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide suppliers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. 3-Nitro-pentafluorpropan-2,2-diol vendor & factory.